Endogenous, non-reducing end glycosaminoglycan biomarkers are superior to internal disaccharide glycosaminoglycan biomarkers for newborn screening of mucopolysaccharidoses and GM1 gangliosidosis
Zackary M. Herbst, Xinying Hong, Leslie Urdaneta, Terri Klein, Christine Waggoner, Hsuan-Chieh Liao, Francyne Kubaski, Roberto Giugliani, Maria Fuller, Michael H. Gelb
Topics & Concepts
MucopolysaccharidosisGlycosaminoglycanBiomarkerDisaccharideMucopolysaccharidosis IChemistryMucopolysaccharidosis type IGalactosemiaEnzyme replacement therapyBiochemistryMedicineInternal medicineGalactoseDiseaseLysosomal Storage Disorders ResearchNeonatal Respiratory Health ResearchCystic Fibrosis Research Advances